The company's weak ROE, falling net income, and retention of...
The company's weak ROE, falling net income, and retention of most profits without sufficient growth may not benefit investors. Future earnings, though, are projected to grow.
Are ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Mixed Financials Driving The Negative Sentiment?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4035Followers
0Following
9036Visitors
Follow